JHL Biotech opens single-use plant based on GE's modular tech

JHL Biotech opens single-use plant based on GE's modular tech

The world’s largest modular cGMP biopharmaceutical manufacturing facility came online this week in Wuhan, China.

Related News

The cell therapy oncology market is expected to reach $30bn by 2030. (Image: iStock)

GE acquires stem cell supplier Biosafe

iStock/ktsimage

GE Healthcare eyeing more cell and gene therapy production tech supplier takeovers

GE: Modular production facilities 'the future of all biologics'

Modular production facilities 'the future of all biologics,' says GE

Image: iStock/NicoElNino

GE Healthcare to add capacity and automation at MA single-use tech plant

JHL's new facility in Wuhan (source JHL)

Sanofi makes play for Chinese biosimilars market in deal with JHL

iStock/dk_photos

Single-use in Ireland on the up? GE Healthcare, Thermo Fisher and NIBRT discuss the trend

Image: iStock/boonsom

Brazilian plant to make Humira biosimilar in 'tobacco-based bioreactors'

Modular facilities solving Biopharma's capacity concerns. Image: c/o Alexander & Asher

Modular single-use facilities rebalance Biopharma’s capacity scales

Nanotherapeutics opts for GE’s modular manufacturing platform

Nanotherapeutics opts for GE’s modular manufacturing platform

Prebuilt modules shipped to China in August (image: GE Healthcare)

JHL completes assembly of GE built off-the-shelf plant in Wuhan, China

Image: istock/Tawintaew

GE and Zenith collaborate on bioprocessing automation

The building's shell arrived in China in August (Image: GE Healthcare)

GE ships pre-built plant to China as Asia pursues homemade production

GE will construct the facility in China after building its parts in Germany

GE to build disposable biopharmaceutical factory for JHL Biotech in China

Related Products

See more related products